Top Buy
| Security | Buy | Sell ▼ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Celldex Therapeutics | 16 | 1 | 3 | 0 | €36.40 | €61.99 | 70.298% |
| Formycon AG | 22 | 1 | 19 | 0 | €52.60 | €89.00 | 69.202% |
| Eledon Pharmaceuticals Inc. | 13 | 1 | 7 | 1 | €2.34 | €4.00 | 70.940% |
| Eli Lilly Corp. | 82 | 1 | 32 | 1 | €835.20 | €900.00 | 7.759% |
| Novo Nordisk A/S ADR | 39 | 1 | 22 | 0 | €124.50 | €150.00 | 20.482% |
| Dr. Reddy's Laboratories Ltd. ADR | 6 | 1 | 0 | 0 | €72.00 | €74.65 | 3.674% |
| Chromadex Corp | 10 | 1 | 0 | 0 | €2.42 | €5.55 | 129.488% |
| Novartis AG ADR | 21 | 1 | 19 | 1 | €102.00 | €110.00 | 7.843% |
| Faron Pharmaceuticals Oy | 2 | 1 | 0 | 1 | €1.60 | €6.15 | 285.338% |
| Gilead Sciences Inc | 31 | 1 | 20 | 0 | €66.45 | €79.54 | 19.704% |
| Stoke Therapeutics Inc | 17 | 1 | 2 | 0 | €12.90 | €20.55 | 59.270% |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 0 | 0 | €53.50 | €50.00 | -6.542% |
| Xencor Inc. | 14 | 1 | 0 | 0 | €18.50 | €31.70 | 71.332% |
| Natural Alternat. | 20 | 1 | 3 | 0 | €5.05 | - | - |
| Ani Pharmaceuticals Inc. | 18 | 1 | 18 | 1 | €58.00 | €69.75 | 20.259% |
| Acadia Pharmaceuticals | 29 | 1 | 3 | 0 | €17.08 | €31.28 | 83.196% |
| GSK plc ADR | 24 | 1 | 21 | 1 | €36.40 | €40.00 | 9.890% |
| Avid Bioservices Inc | 12 | 1 | 10 | 1 | €7.60 | €9.10 | 19.737% |
| Personalis Inc | 8 | 1 | 1 | 0 | €1.99 | €3.26 | 63.404% |
| Amneal Pharmaceuticals Inc | 1 | 1 | 0 | 0 | €7.00 | €10.00 | 42.857% |
| Madrigal Pharmaceuticals inc. | 13 | 1 | 10 | 1 | €243.50 | €310.00 | 27.310% |
| Ocuphire Pharma Inc. | 16 | 1 | 10 | 0 | €1.84 | €3.50 | 89.805% |
| AnaptysBio Inc | 8 | 1 | 0 | 0 | €31.60 | €45.21 | 43.070% |
| Heron Therapeutics Inc. | 20 | 1 | 8 | 0 | €3.33 | €4.65 | 39.700% |
| Medigene AG | 20 | 1 | 19 | 0 | €1.21 | €1.50 | 23.967% |